Jupiter’s medicines help to treat and prevent a range of conditions—from the most common to the most challenging-for the common people. Our specialty product range features solid oral dosage forms (liquids, tablets and capsules), injections, and time release/ controlled release preparations.

Having established brands like Glycoseptol, Carminozyme, Terex and Jvine in the prescriptive Pharma market, it has already forayed into specific therapeutic segments like antibiotics, antiulcerants etc.

Under the expansion programme the specific molecules, which are already in the pipeline, are Azithromycin (antibiotic), the latest macrolide, to be followed shortly by Cefixime (antibiotic) range ; the fastest growing cephalosporin and Rabeprazole ( the latest and safeest PPI). All these molecules are growing at more than three digit figures which show their enormous potential. Besides being high value items, these allows us a higher rate of return from a focused and closely monitored customer base by optimization of all marketing activity and effective cost control.